UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (10), p.1333-1343

2017

Volltextzugriff (PDF)

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD

The European respiratory journal, 2017-10, Vol.50 (4), p.1700451-1700451

2017

Volltextzugriff (PDF)

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Cochrane database of systematic reviews, 2021-04, Vol.4 (4), p.CD007694

2021

Volltextzugriff (PDF)

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability

The AAPS journal, 2024-04, Vol.26 (3), p.56, Article 56

2024

Volltextzugriff (PDF)

Uncovering the regional localization of inhaled salmeterol retention in the lung

Drug delivery, 2018, Vol.25 (1), p.838-845

2018

Volltextzugriff (PDF)

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers

Biopharmaceutics & drug disposition, 2017-10, Vol.38 (7), p.407-419

2017

Volltextzugriff (PDF)

Comparison of inhaled salbutamol and salmeterol for the treatment of arterial hypoxaemia in anaesthetized horses: a randomized clinical trial

Veterinary anaesthesia and analgesia, 2024-09, Vol.51 (5), p.426-432

2024

Volltextzugriff (PDF)

Revealing the Regional Localization and Differential Lung Retention of Inhaled Compounds by Mass Spectrometry Imaging

Journal of aerosol medicine and pulmonary drug delivery, 2020-02, Vol.33 (1), p.43-53

2020

Volltextzugriff (PDF)

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Journal of pharmaceutical sciences, 2017-01, Vol.106 (1), p.313-321

2017

Volltextzugriff (PDF)

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME

American journal of respiratory and critical care medicine, 2019-01, Vol.199 (1), p.43-51

2019

Volltextzugriff (PDF)

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

The AAPS journal, 2015-07, Vol.17 (4), p.871-880

2015

Volltextzugriff (PDF)

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis

PloS one, 2015-09, Vol.10 (9), p.e0137904-e0137904

2015

Volltextzugriff (PDF)

Enantioselective disposition of (R)‐salmeterol and (S)‐salmeterol in urine following inhaled dosing and application to doping control

Drug testing and analysis, 2017-08, Vol.9 (8), p.1262-1266

2017

Volltextzugriff (PDF)

Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial

Respiratory medicine, 2018-06, Vol.139, p.39-47

2018

Volltextzugriff (PDF)

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

Journal of pharmaceutical sciences, 2019-04, Vol.108 (4), p.1401-1403

2019

Volltextzugriff (PDF)

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common)

Journal of clinical pharmacology, 2016-07, Vol.56 (7), p.794-800

2016

Volltextzugriff (PDF)

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

American journal of physiology: Gastrointestinal and liver physiology, 2016-12, Vol.311 (6), p.G998-G1008

2016

Volltextzugriff (PDF)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population

Medicine (Baltimore), 2015-12, Vol.94 (51), p.e2306-e2306

2015

Volltextzugriff (PDF)

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Therapeutic advances in respiratory disease, 2020, Vol.14, p.1753466620968500

2020

Volltextzugriff (PDF)

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

The New England journal of medicine, 2014-10, Vol.371 (14), p.1285-1294

2014

Volltextzugriff (PDF)

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

The lancet respiratory medicine, 2016-05, Vol.4 (5), p.390-398

2016

Volltextzugriff (PDF)

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

American journal of respiratory and critical care medicine, 2008-08, Vol.178 (4), p.332-338

2008

Volltextzugriff (PDF)

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma

The New England journal of medicine, 2019-09, Vol.381 (13), p.1227-1239

2019

Volltextzugriff (PDF)

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison

The European respiratory journal, 2011-02, Vol.37 (2), p.273-279

2011

Volltextzugriff (PDF)

Adherence to inhaled therapy, mortality and hospital admission in COPD

Thorax, 2009-11, Vol.64 (11), p.939-943

2009

Volltextzugriff (PDF)

1 – 25 von 493

Suche als RSS-Feed

Aktive Filter

ThemaBronchodilator Agents - Administration & Dosage

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(454)
Mit Volltextzugriff
(380)

Publikationsform

Artikel
(493)

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(472)
Salmeterol Xinafoate
(465)
Albuterol - Analogs & Derivatives
(462)
Albuterol - Administration & Dosage
(444)
Science & Technology
(348)
Life Sciences & Biomedicine
(345)
Male
(320)
Female
(308)
Administration, Inhalation
(291)
Asthma - Drug Therapy
(274)
Middle Aged
(229)
Fluticasone
(221)
Adult
(215)
Respiratory System
(215)
Androstadienes - Administration & Dosage
(208)
Biological And Medical Sciences
(194)
Medical Sciences
(192)
Double-Blind Method
(183)
Drug Therapy, Combination
(170)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability

Uncovering the regional localization of inhaled salmeterol retention in the lung

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers

Comparison of inhaled salbutamol and salmeterol for the treatment of arterial hypoxaemia in anaesthetized horses: a randomized clinical trial

Revealing the Regional Localization and Differential Lung Retention of Inhaled Compounds by Mass Spectrometry Imaging

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis

Enantioselective disposition of (R)‐salmeterol and (S)‐salmeterol in urine following inhaled dosing and application to doping control

Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common)

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison

Adherence to inhaled therapy, mortality and hospital admission in COPD

Aktive Filter

Suchergebnisse filtern